Table 1.
Response rate and available data at study time points.
| Measure | CHESS+CMa
(n = 148) |
Control (n = 153) |
Total (n = 301) |
|
| Asthma Control Questionnaire | ||||
| Baseline | 145 (98.0%) | 152 (99.3%) | 297 (98.7%) | |
| 3 months | 94 (64%) | 81 (53%) | 175 (58.1%) | |
| 6 months | 85 (57%) | 74 (48%) | 159 (52.8%) | |
| 9 months | 86 (58%) | 63 (41%) | 149 (49.5%) | |
| 12 months | 128 (86.5%) | 121 (79.1%) | 249 (82.7%) | |
| Diary data b | ||||
| Baseline | 128 (86.5%) | 123 (80.4%) | 251 (83.4%) | |
| 3 months | 91 (61%) | 79 (52%) | 170 (56.5%) | |
| 6 months | 84 (57%) | 73 (48%) | 157 (52.2%) | |
| 9 months | 84 (57%) | 65 (42%) | 149 (49.5%) | |
| 12 months | 108 (73.0%) | 110 (72.9%) | 218 (72.4%) | |
| Pharmacy claims data | ||||
| Baseline | 103 (69.6%) | 102 (66.7%) | 205 (68.1%) | |
| 3 months | 64 (43%) | 64 (42%) | 128 (42.5%) | |
| 6 months | 78 (53%) | 75 (49%) | 153 (50.8%) | |
| 9 months | 70 (47%) | 77 (50%) | 155 (48.8%) | |
| 12 months | 59 (40%) | 60 (39%) | 119 (39.5%) | |
a Comprehensive Health Enhancement Support System plus monthly nurse case management.
b Diary data measured symptom-free days and self-reported medication adherence.